Results 1 to 10 of about 709,212 (294)

Atrial fibrillation.

Disease-a-month : DM, 2022
Atrial fibrillation (AF) is the most common cardiac arrhythmia despite substantial efforts to understand the pathophysiology of the condition and develop improved treatments. Identifying the underlying causative mechanisms of AF in individual patients is
Rahul Wadke
semanticscholar   +2 more sources

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation, 2023
AIM The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.
J. Joglar, Mina K. Chung, Anastasia L Armbruster, Emelia J. Benjamin, Janice Y Chyou, Edmond M. Cronin, Anita Deswal, L. Eckhardt, Z. Goldberger, Rakesh Gopinathannair, B. Gorenek, Paul L Hess, M. Hlatky, Gail Hogan, Chinwe Ibeh, J. Indik, Kazuhiko Kido, Fred Kusumoto, Mark S Link, Kathleen T Linta, Gregory M. Marcus, Patrick M McCarthy, Nimesh Patel, Kristen K. Patton, Marco V Perez, J. Piccini, Andrea M. Russo, Prashanthan Sanders, Megan M. Streur, Kevin L Thomas, Sabrina Times, J. Tisdale, Anne Marie Valente, D. V. Van Wagoner   +33 more
semanticscholar   +1 more source

Cardiovascular Hospitalizations and Resource Use Following Atrial Fibrillation Ablation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Over the next few years, atrial fibrillation (AF)–related morbidity and costs will increase significantly. Thus, it is prudent to examine the impact of AF treatment on health care resource use.
Mehak Dhande, Amr Barakat, Ann Canterbury, Floyd Thoma, Suresh Mulukutla, Ahmet Sezer, Konstantinos N. Aronis, Aditya Bhonsale, Krishna Kancharla, Andrew H. Voigt, Norman C. Wang, Alaa Shalaby, N. A. Mark Estes, Samir Saba, Sandeep K. Jain   +14 more
doaj   +1 more source

Fibroblast Growth Factor 21 Protects Against Atrial Remodeling via Reducing Oxidative Stress

Frontiers in Cardiovascular Medicine, 2021
Aim: The structural and electrical changes in the atrium, also known as atrial remodeling, are the main characteristics of atrial fibrillation (AF). Fibroblast growth factor 21 (Fgf21) is an important endocrine factor, which has been shown to play an ...
Miao Chen, Jiawei Zhong, Zhen Wang, Hongfei Xu, Heng Chen, Xingang Sun, Yunlong Lu, Lu Chen, Xudong Xie, Liangrong Zheng   +9 more
doaj   +1 more source

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.

New England Journal of Medicine, 2023
BACKGROUND Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators.
J. Healey, Renato D. Lopes, Christopher B Granger, M. Alings, Lena Rivard, W. Mcintyre, D. Atar, David H. Birnie, G. Boriani, A. Camm, D. Conen, J. Erath, Michael R. Gold, S. Hohnloser, John H. Ip, Josef Kautzner, Valentina Kutyifa, Cecilia Linde, Philippe Mabo, G. Mairesse, Juan Benezet Mazuecos, Jens Cosedis Nielsen, François Philippon, Marco Proietti, C. Sticherling, J. Wong, David J Wright, Ignatius G Zarraga, S. Coutts, Andrew Kaplan, Marta Pombo, F. Ayala-Paredes, Lizhen Xu, K. Simek, Sandra Nevills, R. Mian, S. Connolly   +36 more
semanticscholar   +1 more source

Ibandronate promotes autophagy by inhibiting Rac1–mTOR signaling pathway in vitro and in vivo

Cell Death Discovery, 2022
We previously reported that ibandronate (IBAN) could improve endothelial function in spontaneously hypertensive rats. However, the mechanism by which IBAN improves endothelial function is unclear.
Jie Han, Jian Yang, Qiqi Wang, Xiang Yin, Zewei Sun, Chaoyang Huang, Guoping Chen, Liangrong Zheng, Dongmei Jiang   +8 more
doaj   +1 more source

Obstructive sleep apnea and atrial fibrillation: insights from a bidirectional Mendelian randomization study

BMC Medical Genomics, 2022
Background Observational studies have suggested that obstructive sleep apnea (OSA) is in relation to atrial fibrillation (AF); however, these studies might be confounded and whether the relationship is causal remains unclear. We conducted a bidirectional
Lu Chen, Xingang Sun, Yuxian He, Yunlong Lu, Liangrong Zheng   +4 more
doaj   +1 more source

Incidence, duration, pattern, and burden of de novo atrial arrhythmias detected by continuous ECG monitoring using an implantable loop recorder following ablation of the cavotricuspid isthmus

Cardiovascular Digital Health Journal, 2020
Background: Following cavotricuspid isthmus (CTI) ablation, many patients with atrial flutter (AFL) are diagnosed with atrial fibrillation (AF). The incidence, duration, pattern, and burden of AF remain undefined.
Dan L. Musat, MD, Nicolle S. Milstein, MS, Jacqueline Pimienta, MBS, Advay Bhatt, MD, FHRS, Mark W. Preminger, MD, Tina C. Sichrovsky, MD, Laura Flynn, APN, Carissa Pistilli, APN, Richard E. Shaw, PhD, Suneet Mittal, MD, FHRS   +9 more
doaj   +1 more source

Effectiveness of catheter ablation of atrial fibrillation according to heart failure etiology

Journal of Arrhythmia, 2020
Background Catheter ablation is an important rhythm control therapy in patients with atrial fibrillation (AF) with concomitant heart failure (HF). The objective of this study was to assess the comparative efficacy of AF ablation patients with ischemic vs
Eric Black‐Maier, Benjamin A. Steinberg, Kevin M. Trulock, Frances Wang, Yuliya Lokhnygina, Wanda O'Neal, Sana Al‐Khatib, Brett D. Atwater, James P. Daubert, Camille Frazier‐Mills, Donald D. Hegland, Kevin P. Jackson, Larry R. Jackson, Jason I. Koontz, Robert K. Lewis, Albert Y. Sun, Kevin L. Thomas, Tristram D. Bahnson, Jonathan P. Piccini   +18 more
doaj   +1 more source

Catheter ablation of atrial fibrillation in patients with diabetes mellitus

Heart Rhythm O2, 2020
Background: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM.
Allen Wang, MD, Tracy Truong, MB, Eric Black-Maier, MD, Cynthia Green, PhD, Kristen B. Campbell, PharmD, Adam S. Barnett, MD, Janice Febre, BSN, RN, Zak Loring, MD, MHS, Sana M. Al-Khatib, MD, MHS, FHRS, Brett D. Atwater, MD, James P. Daubert, MD, FHRS, Camille Frazier-Mills, MD, MHS, Donald D. Hegland, MD, Kevin P. Jackson, MD, Larry R. Jackson, MD, Jason I. Koontz, MD, PhD, Robert K. Lewis, MD, PhD, Sean D. Pokorney, MD, MBA, Albert Y. Sun, MD, Kevin L. Thomas, MD, Tristam D. Bahnson, MD, FHRS, Jonathan P. Piccini, MD, MHS, FHRS   +21 more
doaj   +1 more source